This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Agios Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jose Luis Rios Lizarraga: Inventor in Pharmaceutical Research.
Introduction
Jose Luis Rios Lizarraga is an inventor based in Somerville, Massachusetts. His patent work concerns crystalline and amorphous forms of a pharmaceutical compound, and he is associated with Agios Pharmaceuticals, Inc.
Latest Patents
The provided information lists one patent for Rios Lizarraga: “Crystalline forms of N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide.” The patent describes amorphous and crystalline hemisulfate salt forms of the compound, along with pharmaceutical compositions, manufacturing methods, and potential uses. These uses include treating conditions associated with pyruvate kinase, such as pyruvate kinase deficiency. His record includes 1 patent.
Career Highlights
Rios Lizarraga’s listed patent reflects work on pharmaceutical forms and their preparation and therapeutic applications. The provided information identifies Agios Pharmaceuticals, Inc. as his company.
Collaborations
The listed coworkers associated with Rios Lizarraga are Liting Guo and Jacob P. Sizemore.
Conclusion
Jose Luis Rios Lizarraga’s patent activity centers on pharmaceutical formulations and potential treatments for pyruvate kinase-related conditions, including pyruvate kinase deficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile